The Summit for Novel Therapeutics in Oncology Precision Medicine in Cancer (STOP Cancer)

DateLocation
August 7-8, 2026New York Marriott Marquis
1535 Broadway, New York, NY 10036

Please be advised that payments made for exhibits and sponsorships to Horizon CME are non-refundable.

Payment is due within 45 days of completing the registration form. Failure to submit payment within this timeframe will lead to the cancellation of the registrant’s order, and the company will still be responsible for the conference fees.

In the event of a conference postponement, all payments related to exhibits or sponsorships will be automatically transferred to the rescheduled date for the corresponding conference or virtual platform. Additionally, any company that chooses to withdraw from participation in a Horizon CME-organized conference, after making payments for exhibits or sponsorships, will forfeit all funds paid to Horizon CME.

If you require cancellation, please contact Horizon CME directly. Once an order is submitted and approved, you assume financial responsibility.

- Prohibited from distributing pharmaceuticals. Educational materials may be distributed within the designated exhibitor hall only, not within the educational space.
- Exhibitors agree to abide by the Horizon CME policy to not hold any ancillary events associated with the APP Oncology Summit (APPOS) unless otherwise agreed upon by Horizon CME. Horizon CME reserves the right to refuse exhibit space to exhibitors in the event of a violation of this policy.
- All commercial support associated with this activity will be provided with full knowledge of Horizon CME. No additional payments, goods, services, or events will be provided to the course director(s), planning committee members, faculty, joint sponsor, or any other party involved with the activity.
- Completing the online agreement represents a commitment, and payment is due and collectible 45 days before the activity date unless otherwise agreed upon by Horizon CME. Horizon CME reserves the right to refuse exhibit space to the Exhibitor in the event of nonpayment or Code of Conduct violation. No refund is made as a result of such action.
- Horizon CME agrees to provide exhibit space and may acknowledge Exhibitors in activity announcements. Horizon CME reserves the right to assign exhibit space or relocate exhibits at its discretion.
- Insurance: The company must carry comprehensive general liability insurance, with combined single limits of not less than $2 million. It is mutually agreed that Horizon CME shall not be liable to the Company for any damage to or for the loss or destruction of exhibits or the property of the Company, except for damage, loss, or injury caused by or resulting from the negligence of Horizon CME, its employees, representatives, and/or agents. The above-named Company expressly waives all claims for any such damage or loss, except for damage or loss caused by or resulting from the negligence of Horizon CME, its employees, representatives, and/or agents.
- Cancellation: The company must send a written notice of cancellation to Horizon CME. No refunds or transfers will be issued for cancellations.
- Payment: Payments to Horizon CME for exhibits and sponsorships are non-refundable. If a conference is postponed, all payments associated with exhibits or sponsorships will be automatically transferred to the new date for the subject conference. Any Company electing not to participate in a conference held by Horizon CME for which payments were made for exhibit or sponsorship will forfeit all money to Horizon CME.
- Horizon CME Federal Tax ID number is 14-1990948.

Exhibiting at STOP Cancer

IS-APPOS-3

STOP Cancer is a multidisciplinary conference dedicated to advancing innovation in cancer therapeutics and precision medicine. The program brings together clinicians, researchers, scientists, and industry leaders to explore the latest developments shaping the future of oncology care.

Sessions will highlight breakthroughs in novel therapeutic agents, early-phase clinical research, molecular profiling, drug discovery, and precision oncology. Expert faculty will examine current challenges, analyze emerging data, and discuss how advances in clinical trial design and targeted strategies can be applied to improve patient outcomes. Through in-depth presentations and collaborative discussions, STOP Cancer provides participants with critical insights into the evolving landscape of cancer science and precision medicine.

 

We invite you to participate in the following opportunities:
  • Educate clinicians about your company’s new products/services
  • Connect with participating clinical healthcare providers
  • Increase exposure, market/brand awareness, mindshare
  • Share in valuable input and feedback from clinicians regarding industry products/services
proftlk2
proftalk1
What To Expect
  • Two-day conference with at least 3.5 hours of Exhibit Hall time
  • Ability to showcase your product/services
  • In-person meetings offer connection/networking with clinicians
  • Acknowledgement on conference materials
  • Incentives, provided by Horizon CME (no exhibit/sponsor fees are associated with incentives, honorarias, meals) to encourage clinician participation
  • Intended audience of  clinicians, researchers, pharmaceutical industry representatives, and scientists involved in Phase 1 research and
    next-generation sequencing interpretation and application in cancer.
Scroll to Top